Sanchez J P, Domagala J M, Hagen S E, Heifetz C L, Hutt M P, Nichols J B, Trehan A K
Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.
J Med Chem. 1988 May;31(5):983-91. doi: 10.1021/jm00400a016.
A series of 7,8-disubstituted 1-cyclopropyl-6-fluoroquinoline-3-carboxylic acids, 7-substituted 1-cyclopropyl-6-fluoro-1,8-naphthyridine-3-carboxylic acids, and 10-substituted 9-fluoropyridobenzoxazine-6-carboxylic acids has been prepared and evaluated for antibacterial activity. The side chains examined at the 7-position (benzoxazine 10-position) included piperazinyl (g), 3-aminopyrrolidinyl (a), 3-(aminomethyl)pyrrolidinyl (b), and alkylated 3-(aminomethyl)pyrrolidinyl (c-f). Variations at C-8 of the quinolone ring system included hydrogen, nitro, amino, fluorine, and chlorine. The relative enhancement of in vitro activities by the side chains on the 8-hydrogen quinolone and 1,8-naphthyridine against Gram-negative organisms was a greater than b greater than g greater than c-f. The activity imparted to the substituted quinolone nucleus by the 8-substituent was in the order F greater than Cl greater than naphthyridine greater than H greater than benzoxazine greater than NH2 greater than NO2. These trends were retained in vivo.
已制备了一系列7,8-二取代的1-环丙基-6-氟喹啉-3-羧酸、7-取代的1-环丙基-6-氟-1,8-萘啶-3-羧酸和10-取代的9-氟吡啶并苯并恶嗪-6-羧酸,并对其抗菌活性进行了评估。在7位(苯并恶嗪的10位)研究的侧链包括哌嗪基(g)、3-氨基吡咯烷基(a)、3-(氨基甲基)吡咯烷基(b)和烷基化的3-(氨基甲基)吡咯烷基(c-f)。喹诺酮环系统C-8位的变化包括氢、硝基、氨基、氟和氯。8-氢喹诺酮和1,8-萘啶上的侧链对革兰氏阴性菌体外活性的相对增强顺序为a大于b大于g大于c-f。8-取代基赋予取代喹诺酮核的活性顺序为氟大于氯大于萘啶大于氢大于苯并恶嗪大于氨基大于硝基。这些趋势在体内得以保留。